Glucagon-like peptide-1 and glucagon receptor (GLP-1R/GCGR) co-agonism can maximise weight loss and improve glycaemic control in type 2 diabetes and obesity. Here, GCGR is linked to obesity due to melanocortin 4 receptor deficiency.